Sinopharm Group Co (HK:1099) has released an update.
Sinopharm Group Co. Ltd. has scheduled a board meeting for August 23, 2024, to review and approve its unaudited financial results for the first half of the year. Investors and stakeholders are anticipating insights into the company’s performance through June 30, 2024. The meeting will be a significant indicator of Sinopharm’s current financial health and future prospects.
For further insights into HK:1099 stock, check out TipRanks’ Stock Analysis page.
